Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors

In the last few years, immunotherapy has transformed the way we treat solid tumors, including melanoma, lung, head neck, breast, renal, and bladder cancers. Durable responses and long-term survival benefit has been experienced by many cancer patients, with favorable toxicity profiles of immunotherap...

Descripción completa

Detalles Bibliográficos
Autores principales: Arora, Sanjeevani, Velichinskii, Rodion, Lesh, Randy W., Ali, Usman, Kubiak, Michal, Bansal, Pranshu, Borghaei, Hossein, Edelman, Martin J., Boumber, Yanis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778545/
https://www.ncbi.nlm.nih.gov/pubmed/31410780
http://dx.doi.org/10.1007/s12325-019-01051-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778545/
https://www.ncbi.nlm.nih.gov/pubmed/31410780
http://dx.doi.org/10.1007/s12325-019-01051-z

Ejemplares similares